CN Patent

CN116987080A — 作为因子xia抑制剂的具有杂环p2′基团的大环化合物

Assigned to Bristol Myers Squibb Co · Expires 2023-11-03 · 3y expired

What this patent protects

本发明提供式(I)化合物或其立体异构体、互变异构体或药用盐，其中所有变量均如本文中所定义。这些化合物为选择性因子XIa抑制剂或FXIa及血浆激肽释放酶的双重抑制剂。本发明还涉及包含这些化合物的药物组合物及使用其治疗血栓栓塞性和/或炎性病症的方法。

USPTO Abstract

本发明提供式(I)化合物或其立体异构体、互变异构体或药用盐，其中所有变量均如本文中所定义。这些化合物为选择性因子XIa抑制剂或FXIa及血浆激肽释放酶的双重抑制剂。本发明还涉及包含这些化合物的药物组合物及使用其治疗血栓栓塞性和/或炎性病症的方法。

Drugs covered by this patent

Patent Metadata

Patent number: CN116987080A
Jurisdiction: CN
Classification: —
Expires: 2023-11-03
Drug substance claim: No
Drug product claim: No
Assignee: Bristol Myers Squibb Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.